A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis

Blood Cancer Journal, Published online: 29 June 2023; doi:10.1038/s41408-023-00871-1A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis

Source: Blood Cancer Journal - June 29, 2023 Category: Hematology Authors: Jayastu Senapati Muharrem Muftuoglu Jo Ishizawa Hussein A. Abbas Sanam Loghavi Gautam Borthakur Musa Yilmaz Ghayas C. Issa Samuel I. Dara Mahesh Basyal Li Li Kiran Naqvi Rasoul Pourebrahim Elias J. Jabbour Steven M. Kornblau Nicholas J. Short Naveen Pemma Source Type: research